-
Something wrong with this record ?
Circulating exosomal miRNAs as a promising diagnostic biomarker in cancer
R. Lohajová Behulová, A. Bugalová, J. Bugala, E. Struhárňanská, M. Šafranek, I. Juráš
Language English Country Czech Republic
Document type Review, Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
PubMed Central
from 2020
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Circulating MicroRNA * genetics MeSH
- Colorectal Neoplasms * diagnosis genetics MeSH
- Humans MeSH
- MicroRNAs * MeSH
- Biomarkers, Tumor genetics MeSH
- Lung Neoplasms * diagnosis genetics MeSH
- Carcinoma, Non-Small-Cell Lung * diagnosis MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Cancer belongs to multifactorial diseases characterized by uncontrolled growth and proliferation of abnormal cells. Breast cancer, non-small cell lung cancer, and colorectal cancer are the most frequently diagnosed malignancies with a high mortality rate. These carcinomas typically contain multiple genetically distinct subpopulations of tumor cells leading to tumor heterogeneity, which promotes the aggressiveness of the disease. Early diagnosis is necessary to increase patient progression-free survival. Particularly, miRNAs present in exosomes derived from tumors represent potential biomarkers suitable for early cancer diagnosis. Identification of miRNAs by liquid biopsy enables a personalized approach with the subsequent better clinical management of patients. This review article highlights the potential of circulating exosomal miRNAs in early breast, non-small cell lung, and colorectal cancer diagnosis.
Centre of personalized medicine Lambda Life a s Bratislava Slovakia
Comenius University Science Park Bratislava Slovakia
Department of Clinical Genetics St Elizabeth's Cancer Institute Bratislava Slovak Republic
Department of Molecular Biology Faculty of Natural Sciences Comenius University Bratislava Slovakia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23022227
- 003
- CZ-PrNML
- 005
- 20250402155340.0
- 007
- ta
- 008
- 240104s2023 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.935153 $2 doi
- 035 __
- $a (PubMed)37888964
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Lohajová Behulová, Regína $u Department of Clinical Genetics, St Elizabeth's Cancer Institute, Bratislava, Slovak Republic. bugala.juraj@persmed.online $7 xx0329789 $u Institute of Genetics and Molecular Medicine, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia $u Lambda Life a. s., Bratislava, Slovakia
- 245 10
- $a Circulating exosomal miRNAs as a promising diagnostic biomarker in cancer / $c R. Lohajová Behulová, A. Bugalová, J. Bugala, E. Struhárňanská, M. Šafranek, I. Juráš
- 520 9_
- $a Cancer belongs to multifactorial diseases characterized by uncontrolled growth and proliferation of abnormal cells. Breast cancer, non-small cell lung cancer, and colorectal cancer are the most frequently diagnosed malignancies with a high mortality rate. These carcinomas typically contain multiple genetically distinct subpopulations of tumor cells leading to tumor heterogeneity, which promotes the aggressiveness of the disease. Early diagnosis is necessary to increase patient progression-free survival. Particularly, miRNAs present in exosomes derived from tumors represent potential biomarkers suitable for early cancer diagnosis. Identification of miRNAs by liquid biopsy enables a personalized approach with the subsequent better clinical management of patients. This review article highlights the potential of circulating exosomal miRNAs in early breast, non-small cell lung, and colorectal cancer diagnosis.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mikro RNA $7 D035683
- 650 12
- $a nemalobuněčný karcinom plic $x diagnóza $7 D002289
- 650 12
- $a nádory plic $x diagnóza $x genetika $7 D008175
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 650 12
- $a cirkulující mikroRNA $x genetika $7 D000074166
- 650 12
- $a kolorektální nádory $x diagnóza $x genetika $7 D015179
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bugalová, Aneta $7 _AN121931 $u Lambda Life a. s., Bratislava, Slovakia $u Comenius University Science Park, Bratislava, Slovakia
- 700 1_
- $a Bugala, Juraj $7 _AN121932 $u Lambda Life a. s., Bratislava, Slovakia $u Comenius University Science Park, Bratislava, Slovakia
- 700 1_
- $a Struhárňanská, Eva $7 _AN121933 $u Lambda Life a. s., Bratislava, Slovakia $u Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia
- 700 1_
- $a Šafránek, Martin $7 _AN121934 $u Lambda Life a. s., Bratislava, Slovakia $u Department of Experimental Plant Biology, Institute of Botany, Plant Science and Biodiversity Center, Slovak Academy of Sciences, Bratislava, Slovakia
- 700 1_
- $a Juráš, Ivan $7 _AN121935 $u Lambda Life a. s., Bratislava, Slovakia $u Centre of personalized medicine, Lambda Life a. s., Bratislava, Slovakia
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, Suppl. 3 (2023), s. S193-S207
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37888964 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20240104 $b ABA008
- 991 __
- $a 20250402155336 $b ABA008
- 999 __
- $a ok $b bmc $g 2294513 $s 1208671
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 72 $c Suppl. 3 $d S193-S207 $e 2023Oct27 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
- LZP __
- $b NLK124 $a Pubmed-20240104